Fierce Pharma Biopharma News & Insights
Fierce Pharma delivers breaking news and analysis about drug companies, the FDA and the broader pharma industry, including manufacturing, marketing and finance.
Top 20 pharma companies by 2023 revenue - Fierce Pharma
There were changes at the top and the bottom of last year’s top 20 pharma rankings by revenue. And, in between, Novo Nordisk made a significant leap, jumping five spots propelled by skyrocketing ...
The top 20 drugs by worldwide sales in 2023 | Fierce Pharma
It's been several years since COVID-19 vaccines from Pfizer and Moderna jumped to the top of the pharma industry's sales charts, displacing longtime stalwarts with unprecedented sales. But, as ...
Top 10 most anticipated drug launches of 2024 | Fierce Pharma
Every year, we tap Evaluate's annual preview report to assess the biggest potential new drugs of the year ahead. Typically, major pharmaceutical and biotechnology companies are featured, each ...
Trump won a second term. What does it mean for biopharma?
Nov 6, 2024 · On Tuesday night, millions of Americans watched as former president Donald J. Trump gathered up enough electoral votes needed to win the U.S. | Over his first term, Donald Trump advocated for ...
After trial win, Axsome eyes FDA filing for narcolepsy hopeful
Nov 27, 2024 · Once a controversial European depression treatment that never made it to the U.S. market, reboxetine may soon see new life under Axsome Therapeutics' stewardship. Since collecting the exclusive U ...
Gilead’s Kite shortens Yescarta manufacturing time with FDA nod
Jan 30, 2024 · The manufacturing upgrade comes as Kite works through an important launch for Yescarta as a second-line therapy for large B-cell lymphoma. Last month, the FDA allowed additional patient survival ...
Lady Gaga 'shines' in 2nd Nurtec ODT ad for Pfizer - Fierce Pharma
Apr 10, 2024 · Her audience, however, greeted the ad with mixed reactions. Top comments on her two Instagram posts include “Less lady pharma more lady gaga” and “Girl you need new management,” each of ...
2024's Fiercest Women in Life Sciences - fiercepharma.com
This year, like so many others, has been a bit of a mixed bag for women, and especially for those seeking positions of power. For the second time in the last decade, a woman—the U.S.’ first ...
Novartis nabs broader early breast cancer nod than Eli Lilly
Sep 17, 2024 · An FDA approval has officially lifted the curtain on a blockbuster market showdown between Novartis and Eli Lilly in early breast cancer. The FDA has greenlighted Novartis’ Kisqali, used in ...